Del. Co. In Default In Pharma Dispute With Swiss Co.
A Delaware company that produced the active ingredient in a drug used to treat certain pulmonary ailments was found to be in default on Tuesday for not responding to a Swiss...To view the full article, register now.
Already a subscriber? Click here to view full article